CA2457930C - Procede et appareil d'epreuve diagnostique - Google Patents

Procede et appareil d'epreuve diagnostique Download PDF

Info

Publication number
CA2457930C
CA2457930C CA2457930A CA2457930A CA2457930C CA 2457930 C CA2457930 C CA 2457930C CA 2457930 A CA2457930 A CA 2457930A CA 2457930 A CA2457930 A CA 2457930A CA 2457930 C CA2457930 C CA 2457930C
Authority
CA
Canada
Prior art keywords
membrane
vessel
sample
analyte
capture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2457930A
Other languages
English (en)
Other versions
CA2457930A1 (fr
Inventor
Andrew John Sloane
Robert Alan Cole
William Samuel Hunter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proteome Systems Ltd
Original Assignee
Proteome Systems Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR7144A external-priority patent/AUPR714401A0/en
Priority claimed from AU2002950212A external-priority patent/AU2002950212A0/en
Application filed by Proteome Systems Ltd filed Critical Proteome Systems Ltd
Priority claimed from PCT/AU2002/001119 external-priority patent/WO2003016902A1/fr
Publication of CA2457930A1 publication Critical patent/CA2457930A1/fr
Application granted granted Critical
Publication of CA2457930C publication Critical patent/CA2457930C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06—Fluid handling related problems
    • B01L2200/0642—Filling fluids into wells by specific techniques
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0809—Geometry, shape and general structure rectangular shaped
    • B01L2300/0825—Test strips
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/16—Surface properties and coatings
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/04—Moving fluids with specific forces or mechanical means
    • B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/06—Valves, specific forms thereof
    • B01L2400/0633—Valves, specific forms thereof with moving parts
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/973—Simultaneous determination of more than one analyte
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81—Tube, bottle, or dipstick

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Clinical Laboratory Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)

Abstract

L'invention concerne une méthode et un appareil destinés à être utilisés dans un processus de dosage à écoulement traversant. La méthode est caractérisée par une <= pré-étape d'incubation >= dans laquelle l'échantillon à analyser (dans lequel on cherche typiquement à déterminer la présence d'une protéine particulière) et un analyte de détection (typiquement un anticorps lié à de l'or colloïdal ou une étiquette fluorescente) connu pour se lier à la protéine particulière, peuvent se lier ensemble pendant une durée voulue. Cette pré-étape d'incubation se produit avant que le mélange de l'échantillon et de l'analyte de détection ne viennent en contact avec un analyte de capture lié à une membrane. Le fait de prévoir l'étape de pré-incubation a pour effet à la fois d'améliorer la sensibilité du dosage et de réduire le volume d'échantillon nécessaire à un dosage. L'invention concerne également un appareil destiné à mettre en oeuvre la méthode, définissant une chambre de pré-incubation destinée à recevoir l'échantillon ainsi que l'analyte de détection et présentant une base définie par une membrane ainsi qu'une seconde membrane à laquelle l'analyte de capture est lié. Dans une version, la chambre de pré-incubation est portée au-dessus de la seconde membrane, dans une position permettant de la pousser en contact avec la membrane portant l'analyte de capture, permettant ainsi le transfert de fluide depuis la chambre d'incubation à travers la membrane de capture. Dans une autre version, la membrane, à la base de la chambre d'incubation, est hydrophobe et son côté inférieur vient au contact de la membrane de capture, et lorsqu'un agent humidifiant est appliqué au contenu de la chambre de pré-incubation, un transfert de liquide se produit.
CA2457930A 2001-08-20 2002-08-20 Procede et appareil d'epreuve diagnostique Expired - Fee Related CA2457930C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
AUPR7144A AUPR714401A0 (en) 2001-08-20 2001-08-20 Method and apparatus for screening for immunoreactivity against disease
AUPR7144 2001-08-20
AUPR9451 2001-12-12
AUPR945101 2001-12-12
AU2002950212 2002-07-11
AU2002950212A AU2002950212A0 (en) 2002-07-11 2002-07-11 Diagnostic testing process
PCT/AU2002/001119 WO2003016902A1 (fr) 2001-08-20 2002-08-20 Procede et appareil d'epreuve diagnostique

Publications (2)

Publication Number Publication Date
CA2457930A1 CA2457930A1 (fr) 2003-02-27
CA2457930C true CA2457930C (fr) 2012-06-19

Family

ID=32180066

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2457930A Expired - Fee Related CA2457930C (fr) 2001-08-20 2002-08-20 Procede et appareil d'epreuve diagnostique

Country Status (6)

Country Link
US (2) US7205159B2 (fr)
EP (1) EP1419387B1 (fr)
JP (1) JP4264348B2 (fr)
AT (1) ATE539816T1 (fr)
AU (1) AU2002331408B2 (fr)
CA (1) CA2457930C (fr)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE539816T1 (de) * 2001-08-20 2012-01-15 Proteome Systems Ltd Verfahren zum diagnostischen testen
CA2469935C (fr) * 2001-12-12 2014-02-11 Proteome Systems Intellectual Property Pty Ltd. Procede de test de diagnostic
EP1824991B1 (fr) * 2004-11-24 2016-01-20 TechLab, Inc. Dispositif et procede destines a detecter des analytes
US9101927B2 (en) * 2005-01-31 2015-08-11 Realbio Technologies Ltd. Multistep reaction lateral flow capillary device
LT3264094T (lt) 2005-04-04 2021-04-12 Biogen Ma Inc. Imuninio atsako į terapijos agentą įvertinimo būdai
US7824927B2 (en) * 2005-04-05 2010-11-02 George Mason Intellectual Properties, Inc. Analyte detection using an active assay
GB0509422D0 (en) 2005-05-09 2005-06-15 Mabtech Ab Membranes
US7279136B2 (en) 2005-12-13 2007-10-09 Takeuchi James M Metering technique for lateral flow assay devices
US20070224701A1 (en) * 2006-02-16 2007-09-27 Becton, Dickinson And Company Combination vertical and lateral flow immunoassay device
EP4276469A3 (fr) 2006-02-28 2024-01-17 Biogen MA Inc. Procédés de traitement de maladies inflammatoires et auto-immunes avec du natalizumab
EA016626B1 (ru) 2006-03-03 2012-06-29 Элан Фамэсьютикэлс, Инк. Способ лечения натализумабом воспалительного и/или аутоиммунного заболевания (варианты)
AU2007235649A1 (en) * 2006-04-10 2007-10-18 3M Innovative Properties Company Nucleic acid detection using lateral flow methods
EP2053961A4 (fr) * 2006-08-09 2013-05-01 Biogen Idec Inc Procédé de distribution d'un médicament
US7749775B2 (en) * 2006-10-03 2010-07-06 Jonathan Scott Maher Immunoassay test device and method of use
FR2918460B1 (fr) * 2007-07-02 2013-10-04 Najim Chaibi Nouveau dispositif permettant l'obtention des resultats des systemes abo,rhesus et autres pherotypes et systemes rares, rai.
EP2128617A1 (fr) * 2008-05-27 2009-12-02 Koninklijke Philips Electronics N.V. Dispositif et procédés de détection d'analytes dans la salive
WO2010007613A1 (fr) 2008-06-29 2010-01-21 Realbio Technologies Ltd. Dispositif de transfert de liquide particulièrement utile comme dispositif de capture dans un processus de dosage biologique
CA2740902C (fr) * 2008-10-17 2016-10-04 Medmira Inc. Dispositif de diagnostic a ecoulement vers le bas ou vertical et analyse
BRPI0918101A2 (pt) * 2008-12-22 2015-11-24 Koninkl Philips Electronics Nv método para medir a troponina i em uma amostra, cartucho para ser utilizado em um dispositivo de ensaio e uso
KR101024382B1 (ko) 2009-02-19 2011-03-23 주식회사 올메디쿠스 생체물질 분석용 테스트 스트립
US8012770B2 (en) 2009-07-31 2011-09-06 Invisible Sentinel, Inc. Device for detection of antigens and uses thereof
MX2012004105A (es) 2009-10-09 2012-09-07 Invisible Sentinel Inc Dispositivo para deteccion de antigenos y usos del mismo.
CA2776756A1 (fr) 2009-10-11 2011-04-14 Biogen Idec Ma Inc. Tests associes a un anti-vla-4
US11287423B2 (en) 2010-01-11 2022-03-29 Biogen Ma Inc. Assay for JC virus antibodies
IN2012DN06139A (fr) 2010-01-11 2015-09-18 Biogen Idec Inc
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
MX341309B (es) 2010-07-20 2016-08-12 Cephalon Australia Pty Ltd Anticuerpos especificos del heterodimero de anti-il-23.
EP2668501B1 (fr) 2011-01-27 2019-06-12 Invisible Sentinel, Inc. Dispositifs de détection d'analytes, dispositifs multiplexes et de paillasse pour la détection d'analytes, et utilisations de ceux-ci
LT2691530T (lt) 2011-06-10 2018-08-10 Oregon Health & Science University Cmv glikoproteinai ir rekombinantiniai vektoriai
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
CA2850549C (fr) 2011-09-30 2023-03-14 Teva Pharmaceuticals Australia Pty Ltd. Anticorps contre tl1a et leurs utilisations
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
CN105833925B (zh) 2011-12-22 2018-11-13 瑞尔比奥技术有限公司 用于分析物测定的序贯侧向流动毛细管装置
US9005991B2 (en) 2012-01-05 2015-04-14 American Bio Medica Corporation Device and method for testing biological samples
WO2013132347A2 (fr) 2012-03-06 2013-09-12 Calpro As Immunodosage elisa amélioré de la calprotectine
WO2013132338A2 (fr) 2012-03-06 2013-09-12 Calpro As Immunodosage compétitif de la calprotectine
CN104919055B (zh) 2012-03-09 2018-06-19 因威瑟堡善迪诺有限公司 用单一信号检测多种分析物的方法和组合物
FR2991689B1 (fr) 2012-06-11 2018-04-20 Diagast Dispositif de diagnostic immuno-hematologique et utilisations
EP2679596B1 (fr) 2012-06-27 2017-04-12 International Aids Vaccine Initiative Variante de la protéine env du VIH-1
CA2899960C (fr) 2013-02-01 2022-05-03 Transbio Ltd Anticorps anti-cd83 et leur utilisation
JP6545105B2 (ja) 2013-02-07 2019-07-17 シーエスエル、リミテッド Ｉｌ−１１ｒ結合タンパク質及びその使用
US9588114B2 (en) 2013-04-23 2017-03-07 Montecito Bio Sciences Ltd Flow through testing system with pressure indicator
US10119976B2 (en) 2013-05-28 2018-11-06 Biogen Ma Inc. Method of assessing risk of PML
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US11033896B2 (en) * 2014-08-08 2021-06-15 Ortho-Clinical Diagnostics, Inc. Lateral-flow assay device with filtration flow control
NZ731491A (en) 2014-10-23 2021-12-24 Kira Biotech Pty Ltd Cd83 binding proteins and uses thereof
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (fr) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Trimères de glycoprotéines de l'enveloppe du vih-1 soluble
CA2984987C (fr) 2015-05-05 2023-10-10 Mesoblast International Sarl Test d'activite biologique
KR102660506B1 (ko) 2017-05-04 2024-04-25 메조블라스트 인터내셔널 에스에이알엘 면역억제가 향상된 간충직 계통 전구체 또는 줄기 세포
GB201811597D0 (en) 2018-07-16 2018-08-29 Hemogad Tech Ltd Analyser
JP2022515916A (ja) 2019-01-02 2022-02-22 メゾブラスト・インターナショナル・エスアーエールエル 腰痛を治療するための方法
AU2021323475A1 (en) 2020-08-10 2023-04-13 Mesoblast International Sarl A composition comprising mesenchymal precursor or stem cells and their use
WO2024009226A1 (fr) 2022-07-05 2024-01-11 Mesoblast International Sarl Intermédiaire cryoconservé et test d'activité biologique pour celui-ci

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US124077A (en) * 1872-02-27 Improvement in processes for desulphurizing ores
US570049A (en) * 1896-10-27 peelich
US631288A (en) * 1899-04-17 1899-08-22 Julius Fey Bag-holder.
US4246339A (en) * 1978-11-01 1981-01-20 Millipore Corporation Test device
TW203120B (fr) * 1985-10-04 1993-04-01 Abbott Lab
US5514602A (en) * 1986-06-09 1996-05-07 Ortho Diagnostic Systems, Inc. Method of producing a metal sol reagent containing colloidal metal particles
US5763262A (en) * 1986-09-18 1998-06-09 Quidel Corporation Immunodiagnostic device
US5137691A (en) * 1987-01-27 1992-08-11 V-Tech, Inc. Antibody testing system with removable air gap
US4912034A (en) * 1987-09-21 1990-03-27 Biogenex Laboratories Immunoassay test device and method
US5137804A (en) 1988-05-10 1992-08-11 E. I. Du Pont De Nemours And Company Assay device and immunoassay
US4877586A (en) * 1988-07-27 1989-10-31 Eastman Kodak Company Sliding test device for assays
ES2070264T3 (es) * 1989-06-05 1995-06-01 Janssen Pharmaceutica Nv Un analisis en fase solida para uso con un revelador fisico.
US5185127A (en) * 1989-09-21 1993-02-09 Becton, Dickinson And Company Test device including flow control means
JP3070764B2 (ja) 1990-03-12 2000-07-31 バイオサイト・ダイアグノスティックス・インコーポレイテッド 生物学的検定装置及びそれを用いた検定方法
DE563858T1 (de) * 1992-04-01 1994-03-03 Nihon Millipore Kogyo K K Verfahren zur Bestimmung der Anzahl lebender Mikroorganismen.
GB9322650D0 (en) 1993-11-03 1993-12-22 Cogent Diagnostics Ltd Analytical device
US5658801A (en) 1994-05-03 1997-08-19 Spectral Diagnostics Inc. Medical test kit
AUPM765894A0 (en) * 1994-08-26 1994-09-15 University Of Sydney, The Particle detection and identification
US20010051350A1 (en) 1995-05-02 2001-12-13 Albert Nazareth Diagnostic detection device and method
CA2266747A1 (fr) * 1996-09-25 1998-04-02 Mary Ann Childs Dispositif pour epreuve diagnostique ameliorant la circulation des fluides et la resistance aux interactions chimiques
GB9700759D0 (en) 1997-01-15 1997-03-05 Carbury Herne Limited Assay device
US6057165A (en) 1997-02-07 2000-05-02 Becton, Dickinson And Company Quality control procedure for membrane flow-through diagnostic assay devices
US5885526A (en) 1997-03-25 1999-03-23 Chu; Albert E. Analytical device for membrane-based assays
ES2323540T3 (es) * 1997-07-16 2009-07-20 Charm Sciences Inc. Metodo para detectar la presencia de un analito residual en una muestra.
AUPP131098A0 (en) * 1998-01-13 1998-02-05 Bellon Pty Limited Identification of particles and macromolecular species
US6312888B1 (en) 1998-06-10 2001-11-06 Abbott Laboratories Diagnostic assay for a sample of biological fluid
EP1086375A4 (fr) 1998-06-12 2004-12-15 New Horizons Diagnostics Inc Essais colorimetriques colloidaux en ecoulement continu et en ecoulement lateral utilisant des particules submicroniques solubles
US6287783B1 (en) * 1999-03-18 2001-09-11 Biostar, Inc. Optical assay device and method
US6436722B1 (en) * 2000-04-18 2002-08-20 Idexx Laboratories, Inc. Device and method for integrated diagnostics with multiple independent flow paths
WO2002031465A1 (fr) * 2000-10-13 2002-04-18 Inhalix Pty Ltd Ensemble de particules a analyser au moyen de systemes d"essai
US6565808B2 (en) 2001-05-18 2003-05-20 Acon Laboratories Line test device and methods of use
US7531362B2 (en) * 2001-06-07 2009-05-12 Medmira Inc. Rapid diagnostic assay
ATE539816T1 (de) 2001-08-20 2012-01-15 Proteome Systems Ltd Verfahren zum diagnostischen testen
CA2469935C (fr) 2001-12-12 2014-02-11 Proteome Systems Intellectual Property Pty Ltd. Procede de test de diagnostic

Also Published As

Publication number Publication date
EP1419387B1 (fr) 2012-01-04
EP1419387A4 (fr) 2005-12-14
US20050124077A1 (en) 2005-06-09
JP4264348B2 (ja) 2009-05-13
AU2002331408B2 (en) 2008-05-08
US20070190667A1 (en) 2007-08-16
JP2004538488A (ja) 2004-12-24
ATE539816T1 (de) 2012-01-15
US7205159B2 (en) 2007-04-17
EP1419387A1 (fr) 2004-05-19
CA2457930A1 (fr) 2003-02-27

Similar Documents

Publication Publication Date Title
CA2457930C (fr) Procede et appareil d&#39;epreuve diagnostique
EP1461615B1 (fr) Procede de test de diagnostic
AU2002331408A1 (en) Diagnostic testing process and apparatus
US10620095B2 (en) Apparatus and methods for detecting analytes
US7344893B2 (en) Immuno-gold lateral flow assay
WO2003016902A1 (fr) Procede et appareil d&#39;epreuve diagnostique
US20080318342A1 (en) Diagnostic Testing Process and Apparatus Incorporating Controlled Sample Flow
US20110229913A1 (en) Method for Amplification of Signal in Immunochromatographic Assay and Immunochromatographic Kit Using the Method
WO2005029073A2 (fr) Procedes et dispositif de dosage chromatographique
WO2012075251A1 (fr) Dispositif de mesure d&#39;échantillons et dispositif d&#39;analyse avec dilution d&#39;échantillon intégrée
WO2012075256A2 (fr) Dispositif doseur d&#39;échantillon et dispositif d&#39;analyse comportant la dilution intégrée de l&#39;échantillon
WO2012075258A2 (fr) Procédé de dosage immunologique ratiométrique et dispositif d&#39;analyse sanguine
AU2002350271B2 (en) Diagnostic testing process
CN116964452A (zh) 用于快速分析来自受试者的毛细血管血样以旨在检测所述毛细血管血样中至少一种分析物的存在的系统
Takahashi Biosensor

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160822